Condition
Central Line Associated Blood Stream Infections (CLABSI) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Central Line Associated Blood Stream Infections (CLABSI) clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Turkey (Türkiye) (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Machine learning alerts to reduce central line bloodstream infections
This trial will try a machine learning alert system given to hospital infection prevention teams to reduce bloodstream infections in hospitalized adults with central lines.
-
Comparing DEFENCATH® to Heparin for Preventing Infections in Patients on Total Parenteral Nutrition
This study is testing whether a new solution called DEFENCATH® can better prevent infections in adults who are getting nutrition through a central line compared to the standard treatment with heparin.
Quick answers
How many Central Line Associated Blood Stream Infections (CLABSI) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.